Real-world data from the Japanese National Health Insurance System enable fine phenotyping in a 14K-scale population-based study
Yayoi Otsuka‐Yamasaki, Naoyuki Nishiya, Yoichi Sutoh, Reiko Aoyama, Kozo Tanno, Motoki Nakao, Shohei Komaki, Shiori Minabe, Hideki Ohmomo, Koichi Asahi, Yasushi Ishigaki, Makoto Sasaki, Atsushi Shimizu
The paper uses Japanese health insurance claims data to improve disease prevalence estimation and GWAS results for Alzheimer's and Parkinson's diseases.
medRxiv · Oct 6, 2025 · PreprintGenetic & Genomic Medicine